Methods for assessing cardiovascular status and compositions for use thereof
CA 2285671 A1 · Owner: Biotage Ab · Inventors: Norberg, Leif Torbjorn; Andersson, Maria Kristina; Lindstrom, Per Harry Rutger
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides methods for assessing cardiovascular status in an individual, which comprise determining the sequence at one or more polymorphic positions within the human genes encoding angiotensin converting enzyme (ACE), angiotensinogen (AGT), and/or type 1 angiotensin II receptor (AT~). The invention also provides isolated nucleic acids endoding ACE AGT, and AT~, polymorphisms, nucleic acid probes that hybridize to polymorphic positions kits for the prediction of cardiovascular status and nucleic, acid and peptide targets for use in identifying candidate cardiovascular drugs.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 1, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 1, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 1, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.